3 833

Cited 7 times in

Achieving recommended low density lipoprotein cholesterol goals and the factors associated with target achievement of hypercholesterolemia patients with rosuvastatin in primary care

DC Field Value Language
dc.contributor.author강희철-
dc.date.accessioned2014-12-18T08:49:54Z-
dc.date.available2014-12-18T08:49:54Z-
dc.date.issued2013-
dc.identifier.issn0300-7995-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/87031-
dc.description.abstractOBJECTIVE: Hypercholesterolemia is a major risk factor for cardiovascular disease and requires continuous management. The role of primary physicians in this regard is important, yet the factors associated with successful lipid lowering treatments in primary clinics have not been clearly identified. We aimed to evaluate the rate of successful hypercholesterolemia treatment in Korean primary care, and to identify the factors associated with achieving low density lipoprotein cholesterol (LDL-C) targets. METHODS: We prospectively recruited and retrospectively assessed 1851 Korean patients with hypercholesterolemia who visited family physicians and were prescribed rosuvastatin for the first time. LDL-C lowering targets, defined according to NCEP ATP III guidelines, were evaluated at 6 months after the first prescription. The factors associated with achieving these targets were also assessed. RESULTS: Overall, 87.6% of our participants attained their LDL-C goals. In multiple logistic regression analysis, good adherence to medication was strongly associated with the achievement of target LDL-C levels, whereas higher cardiovascular risk factors including diabetes (in both sexes), low high density lipoprotein, and current smoking status (in males), and hypertension (in females) were related to LDL-C target level failures. CONCLUSION: Our observations of the short period for hypercholesterolemia in Korean primary care has revealed that the rate of achieving target LDL-C levels was high in these patients, whereas patients at higher risk for cardiovascular disease tended to have lower LDL-C achievement outcomes. Primary care physicians should pay more attention to patients showing higher cardiovascular risk and stress the need for good adherence and management regimens in these individuals.-
dc.description.statementOfResponsibilityopen-
dc.relation.isPartOfCURRENT MEDICAL RESEARCH AND OPINION-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHCardiovascular Diseases/drug therapy-
dc.subject.MESHCardiovascular Diseases/prevention & control-
dc.subject.MESHCholesterol, LDL/blood*-
dc.subject.MESHFemale-
dc.subject.MESHFluorobenzenes/therapeutic use*-
dc.subject.MESHHumans-
dc.subject.MESHHydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use*-
dc.subject.MESHHypercholesterolemia/drug therapy*-
dc.subject.MESHHypertension/complications-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHProspective Studies-
dc.subject.MESHPyrimidines/therapeutic use*-
dc.subject.MESHRepublic of Korea-
dc.subject.MESHRetrospective Studies-
dc.subject.MESHRisk Factors-
dc.subject.MESHRosuvastatin Calcium-
dc.subject.MESHSmoking-
dc.subject.MESHSulfonamides/therapeutic use*-
dc.subject.MESHSurveys and Questionnaires-
dc.titleAchieving recommended low density lipoprotein cholesterol goals and the factors associated with target achievement of hypercholesterolemia patients with rosuvastatin in primary care-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Family Medicine (가정의학)-
dc.contributor.googleauthorJung Ah Lee-
dc.contributor.googleauthorSung Sunwoo-
dc.contributor.googleauthorYoung Sik Kim-
dc.contributor.googleauthorHan Jin Oh-
dc.contributor.googleauthorHee-Cheol Kang-
dc.contributor.googleauthorKyung-Chae Park-
dc.contributor.googleauthorDong Hyuk Sin-
dc.contributor.googleauthorSang Yeoup Lee-
dc.contributor.googleauthorYun Jun Yang-
dc.contributor.googleauthorByung Yeon Yu-
dc.contributor.googleauthorChul-Min Kim-
dc.identifier.doi10.1185/03007995.2013.802683-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00105-
dc.relation.journalcodeJ00667-
dc.identifier.eissn1473-4877-
dc.identifier.pmid23647398-
dc.identifier.urlhttp://informahealthcare.com/doi/abs/10.1185/03007995.2013.802683-
dc.subject.keywordAchievement-
dc.subject.keywordFramingham risk-
dc.subject.keywordPrimary care-
dc.subject.keywordRosuvastatin-
dc.subject.keywordTarget LDL-C-
dc.contributor.alternativeNameKang, Hee Cheol-
dc.contributor.affiliatedAuthorKang, Hee Cheol-
dc.rights.accessRightsnot free-
dc.citation.volume29-
dc.citation.number7-
dc.citation.startPage751-
dc.citation.endPage760-
dc.identifier.bibliographicCitationCURRENT MEDICAL RESEARCH AND OPINION, Vol.29(7) : 751-760, 2013-
dc.identifier.rimsid32111-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Family Medicine (가정의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.